PMC:7536954 / 5053-5216
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T66 | 28-32 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T67 | 39-48 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T68 | 144-152 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T69 | 153-162 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T42 | 56-74 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
175 | 56-74 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
185 | 28-48 | Disease | denotes | SARS‐Cov‐2 infection | MESH:C000657245 |
186 | 144-152 | Disease | denotes | COVID‐19 | MESH:C000657245 |
187 | 153-162 | Disease | denotes | infection | MESH:D007239 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T42 | 0-163 | Sentence | denotes | Notably, our case developed SARS‐Cov‐2 infection during hydroxychloroquine therapy, which is under evaluation for the current management of the COVID‐19 infection. |